According to the latest report “Animal Vaccines Market by Type (Porcine, Poultry, Companion Animal, Aquaculture), Disease (Porcine Parvovirus, Swine Pneumonia, Avian Influenza, Rabies, Clostridial Diseases), Technology (Inactivated, Toxoid, Recombinant) - Global Forecast to 2022.”
in 2016 at a CAGR of 5.9%. The base year considered for the study is 2016 and the forecast for the market size is provided for the period between 2017 and 2022. The major factors driving the growth of this market include growth in livestock population and repeated breakouts of livestock diseases; increasing adoption of companion animals; rising incidence of zoonotic diseases; initiatives by various government agencies, animal associations, and leading players; and the introduction of new types of vaccines.
Download FREE PDF Sample Pages of Animal Vaccines Market @: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1233
Research Methodology
Top-down and bottom-up approaches were used to validate the size of the global veterinary vaccines market and estimate the size of various other dependent submarkets. Major players in the market were identified through secondary research and their market revenues were determined through primary and secondary research. Secondary research included the study of the annual and financial reports of top market players, whereas primary research included extensive interviews with the key opinion leaders such as CEOs, directors, and marketing executives. The percentage splits, shares, and breakdowns of the segments were determined using secondary sources and verified through primary sources. This data is consolidated and added to detailed inputs and analysis from MarketsandMarkets and presented in this report. Some of the secondary resources referred to are World Society for the Protection of Animals, Animal Health Institute, American Pet Products Association, World Organisation for Animal Health, Department of Livestock Development, Ministry of Agriculture and Cooperatives, Federation of Asian Veterinary Associations, and Thai Veterinary Medical Association.
The market is classified into live attenuated vaccines, inactivated vaccines, toxoid vaccines, recombinant vaccines and other vaccines on the basis of technology. The live attenuated vaccines segment is expected to account for the largest share of the veterinary vaccines market in 2017. The ease of administration and long-term immunity offered by live attenuated vaccines are factors driving the adoption of this technology.
Factors such as high storage cost for vaccines is expected to restrain animal vaccines market growth to a certain extent.
To Get More Information, Talk to Our Experts @: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=1233
The key players in the veterinary vaccines market include Zoetis (US), Merck Animal Health (US), Elanco Animal Health (US), Boehringer Ingelheim (Germany), Ceva (France), Phibro Animal Health (US), and Virbac (France).
Download FREE PDF Sample Pages of Animal Vaccines Market @: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1233
Research Methodology
Top-down and bottom-up approaches were used to validate the size of the global veterinary vaccines market and estimate the size of various other dependent submarkets. Major players in the market were identified through secondary research and their market revenues were determined through primary and secondary research. Secondary research included the study of the annual and financial reports of top market players, whereas primary research included extensive interviews with the key opinion leaders such as CEOs, directors, and marketing executives. The percentage splits, shares, and breakdowns of the segments were determined using secondary sources and verified through primary sources. This data is consolidated and added to detailed inputs and analysis from MarketsandMarkets and presented in this report. Some of the secondary resources referred to are World Society for the Protection of Animals, Animal Health Institute, American Pet Products Association, World Organisation for Animal Health, Department of Livestock Development, Ministry of Agriculture and Cooperatives, Federation of Asian Veterinary Associations, and Thai Veterinary Medical Association.
The market is classified into live attenuated vaccines, inactivated vaccines, toxoid vaccines, recombinant vaccines and other vaccines on the basis of technology. The live attenuated vaccines segment is expected to account for the largest share of the veterinary vaccines market in 2017. The ease of administration and long-term immunity offered by live attenuated vaccines are factors driving the adoption of this technology.
Factors such as high storage cost for vaccines is expected to restrain animal vaccines market growth to a certain extent.
To Get More Information, Talk to Our Experts @: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=1233
The key players in the veterinary vaccines market include Zoetis (US), Merck Animal Health (US), Elanco Animal Health (US), Boehringer Ingelheim (Germany), Ceva (France), Phibro Animal Health (US), and Virbac (France).
Comments
Post a Comment